// App-Quantinova.ai

P317 : Characterisation of patients with delayed response to ustekinumab for Crohn’s disease

Researchers

Presenter

  • B E Sands

Principal Investigators

  • A Oortwijn

  • N Rijnders

  • J Izanec

  • C Gasink

  • D Jacobstein

  • O J Adedokun

  • L-L Gao

  • J-F Colombel

  • S Targan

  • S Ghosh

  • W J Sandborn

Medical Centers

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Janssen Biologics, Leiden, Netherlands

  • Janssen Scientific Affairs, Horsham, PA

  • Janssen Research and Development, LLC, Spring House, PA

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • University of Birmingham, Birmingham, United Kingdom

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • C reactive protein

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved